Table 2.

Encapsulation efficiency (EE) and loading capacity (LC) of different formulations (n=6)

Formulation	EE (%)	LC (%)
PTX NPs	23.96±1.62	1.45±0.10
PTX TNPs	22.86±1.21	1.38±0.07
DiR NPs	48.88±4.25	0.45±0.04
DiR TNPs	37.51±3.11	0.33±0.03
Coumarin 6 NPs	48.21±3.98	1.10±0.09
Coumarin 6 TNPs	47.01±4.22	1.07±0.09

Abbreviations: NPs, nanoparticles; CREKA, cysteine–arginine–glutamic acid– lysine–alanine; TNPs, CREKA-conjugated NPs; DiR, 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindotricarbocyanine iodide; PTX, paclitaxel.